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Skeletal disorders and neural tube closure defects represent clinically significant human malformations. The
signaling networks regulating normal skeletal patterning and neurulation are largely unknown. Targeted
mutation of the active site lysine of MEK kinase 4 (MEKK4) produces a kinase-inactive MEKK4 protein
(MEKK4K1361R). Embryos homozygous for this mutation die at birth as a result of skeletal malformations and
neural tube defects. Hindbrains of exencephalic MEKK4K1361R embryos show a striking increase in neuroep-
ithelial cell apoptosis and a dramatic loss of phosphorylation of MKK3 and -6, mitogen-activated protein
kinase kinases (MKKs) regulated by MEKK4 in the p38 pathway. Phosphorylation of MAPK-activated protein
kinase 2, a p38 substrate, is also inhibited, demonstrating a loss of p38 activity in MEKK4K1361R embryos. In
contrast, the MEK1/2–extracellular signal-regulated kinase 1 (ERK1)/ERK2 and MKK4–Jun N-terminal
protein kinase pathways were unaffected. The p38 pathway has been shown to regulate the phosphorylation and
expression of the small heat shock protein HSP27. Compared to the wild type, MEKK4K1361R fibroblasts
showed significantly reduced phosphorylation of p38 and HSP27, with a corresponding heat shock-induced
instability of the actin cytoskeleton. Together, these data demonstrate MEKK4 regulation of p38 and that
substrates downstream of p38 control cellular homeostasis. The findings are the first demonstration that
MEKK4-regulated p38 activity is critical for neurulation.
Mitogen-activated protein kinases (MAPKs) can be divided
into five distinct groups that include extracellular signal-regu-
lated kinase 1 (ERK1) and ERK2, c-Jun N-terminal kinase
(JNK), p38, ERK3 and ERK4, and ERK5 (10, 34). Each
MAPK is activated by MAPK kinases (MAP2Ks). ERK1 and
ERK2 are phosphorylated by MEK1 and MEK2 and are pri-
marily activated by growth-promoting stimuli. JNK is activated
by its MAP2Ks, MAPK kinase 4 (MKK4) and MKK7, whereas
p38 is primarily activated by MKK3 and MKK6 (MKK3/6) but
can be phosphorylated by MKK4 under some circumstances
(4). JNK and p38 are mainly activated by stress stimuli and
cytokines but can also be stimulated by growth factors.
MAP2Ks are in turn regulated by MAPK kinase kinases
(MAP3Ks). MEK kinase 4 (MEKK4) is a MAP3K that regu-
lates p38 and JNK through the phosphorylation of the
MAP2Ks MKK3 and MKK6 and MKK4 and MKK7, respec-
tively (11, 31). The physiological role of MEKK4 is poorly
defined, and the pathways that promote MEKK4 signaling to
MAPKs are largely unknown.
Vertebrate development is orchestrated by cell-cell interac-
tions and cytokine gradients that regulate intracellular signal-
ing networks. We have discovered that MEKK4 expression is
regulated during development and is a critical node for the
control of neural tube closure and skeletal patterning in the
developing mouse embryo. In this report, we investigated the
function of MEKK4 in development by the targeted inhibition
of MEKK4 kinase activity. The MEKK4 gene was altered by
the targeted mutation of the active site lysine to an arginine,
thereby eliminating phosphotransferase activity such that the
expressed MEKK4K1361R protein is unable to activate
MAP2Ks. Expression of kinase-inactive MEKK4 inhibited
MKK3/6 and p38 signaling and enhanced apoptosis in the
hindbrains of mutant mice. Recently, deletion of the MEKK4
gene has been shown to result in exencephaly and spina bifida
(6). This phenotype was attributed to a modest decrease in
phosphorylation of MKK4 in the hindbrains of knockout em-
bryos (6). Similar to the MEKK4 knockout, MEKK4 kinase-
inactive embryos exhibit exencephaly and spina bifida. How-
ever, loss of phosphorylation of MKK4 was not observed in
MEKK4 kinase-inactive embryos or in fibroblasts derived from
these embryos. Instead, we observed inhibition of MKK3 and
MAPK-activated protein kinase 2 (MAPKAPK-2) in both mu-
tant hindbrains and fibroblasts. Additional defects not ob-
served in the MEKK4 knockout including rib and vertebral
malformations and significant infertility were found with the
kinase-inactive MEKK4 mice, consistent with the prediction
that kinase-inactive MEKK4 would be able to influence signal-
ing as an inhibitory mutant in a stronger and more dramatic
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way than a traditional knockout where the protein was not
expressed. The findings uniquely define MEKK4 as a critical
node required for normal development of the mouse embryo,
and its kinase activity is important for regulation of the MKK3/
p38/MAPKAPK-2 pathway.
MATERIALS AND METHODS
In situ hybridization. An N-terminal MEKK4 riboprobe was generated by
BamHI digestion of hemagglutinin (HA)-MEKK4 in pCMV5 (11). The 2-kb
BamHI fragment corresponding to nucleotides 105 to 2096 of murine MEKK4
was subcloned into pcDNA3() in both the forward and reverse orientations,
resulting in both antisense and sense orientations under the T7 promoter. The
riboprobe to brachyury was generated as previously described (36). In situ hy-
bridization was performed as previously described (33). Digoxigenin-labeled
probes at 1 g/ml were hybridized to either whole-mount embryos or 8- to
10-m-thick cryosections on glass slides as previously described (24). Whole
embryos or sections were incubated with alkaline-phosphatase antidigoxigenin
antibodies, followed by incubation with BM purple (Boehringer Mannheim) or
nitroblue tetrazolium–5-bromo-4-chloro-3-indolylphosphate solution (Roche).
Generation of MEKK4K1361R mice. Genomic DNA encoding exons 18 through
23 was PCR cloned from 129Sv wild-type (wt) mouse DNA. A 3.5-kb fragment
encoding exons 18 to 21 was inserted at the 5 end of the targeting vector
Osdupdel (a gift from O. Smithies). Two mutations were generated in exon 21.
A silent mutation introduced an SacI site in codon 1357, from CTG to CTC. In
codon 1361, a single-nucleotide change from AAG to AGG produced the re-
placement of the active site lysine by an arginine. A 2.5-kb fragment encoding
exons 22 to 23 was inserted at the 3 end of the targeting vector. The neomycin
resistance gene was in the reverse orientation. Outside the region of homology,
the thymidine kinase gene was present for negative selection. The targeting
construct was electroporated into 129Sv embryonic stem (ES) cells. Homologous
recombination in two ES cell clones was confirmed by Southern blot analysis with
a probe outside the region of homology and by PCR from outside the region of
the targeting vector. Southern blot analysis was performed using standard tech-
niques with a 500-bp probe to intron 23 using primers 5 CGTTCTGAGCAGT
TGCACTGGAAG 3 and 5 CCTACAATCAACATGCACACCCATC 3. ES
cells were injected into C57BL/6 blastocysts. Founder males were mated with
129Sv females (Taconic), and heterozygotes were crossed. Germ line transmis-
sion was verified by Southern blot analysis as described above and by PCR. PCR
primers in exons 21 and 22, respectively, were 5 GACACAGGGGAGCTGAT
GGCCATGAGGGAG 3 and 5 GTGAAGCTCCACGCCAAAATACCG 3.
Experiments were performed on embryos and mice generated from
MEKK4K1361R heterozygote crosses in a mixed C57BL/6 129/SvE background.
The neo cassette was not excised from the MEKK4K1361R germ line. Several
studies have shown the ability of the neo cassette to disrupt gene splicing, thus
abrogating expression of the protein. Western blotting of lysates from multiple
primary cell types showed equal protein expression in MEKK4K1361R cells rela-
tive to that in the wild type, demonstrating that the neo cassette does not
interfere with MEKK4K1361R expression. Further, total RNA was isolated from
primary cells, and reverse transcription-PCR demonstrated no significant differ-
ence in message size in MEKK4K1361R cells relative to that of the wild type. All
experiments using animals were performed in compliance with all federal and
institutional policies.
Skeletal preparations. For staining of cartilage and bone, embryonic day 18.5
(E18.5) fetuses were prepared as previously described (7). Cartilage was detected
with Alcian blue 8GX (Sigma) and bone was detected with Alizarin red S
(Sigma).
Hindlimb micromass cultures. E11.5 embryos from MEKK4K1361R/wt crosses
were isolated, and limbs were dissected and cultures prepared as previously
described (3). Cultures were stained with Alcian blue to detect cartilage.
Preparation of E14.5 primary MEFs. Primary mouse embryo fibroblasts
(MEFs) were prepared from embryos isolated at E14.5. Head, limbs, liver, and
heart were removed. Embryos were dissociated by passage three times through
an 18-gauge needle, followed by trypsinization at 37°C. Cells were cultured in
Iscove’s modified Dulbecco’s medium containing 10% heat-inactivated fetal bo-
vine serum, 1% penicillin, and 1% streptomycin. Experiments were performed
with both primary and spontaneously immortalized cells. Fibroblasts from mul-
tiple wild-type and MEKK4K1361R littermate embryos were examined with nearly
identical results. A total of 200 g of MEF lysate was probed with an affinity-
purified rabbit polyclonal antibody to full-length murine MEKK4.
Embryology and histology. Depending on the age of the embryo, tail or yolk
sac samples were used to genotype embryos. For histology, fetuses were isolated
at E18.5, fixed whole, paraffin embedded, sectioned, and stained with hematox-
ylin and eosin by standard methods. For terminal deoxynucleotidyltransferase-
mediated dUTP-biotin nick end labeling (TUNEL) and phospho-antibody stain-
ing, embryos were isolated on E9.5 and fixed in 4% paraformaldehyde for 4 h.
Embryos were processed as previously described for in situ hybridizations.
TUNEL staining was performed on cryosections according to the manufacturer’s
specifications (Roche). For phospho-MKK3/6, phospho-MKK4, phospho-
MEK1/2, and phospho-MAPKAPK-2 staining, cryosections were permeabilized
for 10 min in 0.1% Triton in Tris-buffered saline, pH 7.4. Sections were washed,
blocked in 10% donkey serum, and incubated overnight with anti-phospho-
specific antibodies diluted 1:500 in Tris-buffered saline and 5% bovine serum
albumin. Sections were washed and incubated with DAPI (4,6-diamidino-2-
phenylindole; 0.04 ng/ml) and Cy3 donkey anti-rabbit diluted 1:500. Imaging was
performed using an Axiovert 200 M microscope from Zeiss (Germany) and
imaging software from Intelligent Imaging Innovations (Denver, Colo.). To mea-
sure fluorescence intensity, autofluorescence was subtracted from all images.
Then, the mean fluorescence intensity of each antibody staining was measured in
the entire hindbrain along a two-cell thickness of the neuroepithelium lining the
ventricles. Statistical significance was determined by Student’s t-test analysis.
Western blot analysis, immunoprecipitations, and kinase assays. MEFs were
treated as described in the figure legends. For total-cell lysates, cells were lysed
in buffer A containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton-X, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium van-
adate, 0.05 mM dithiothreitol, 1 g/ml leupeptin, and 17 g/ml aprotinin. A total
of 15 g of lysate was subjected to Western blotting with phospho-specific
antibodies against p38, JNK, ERK, MKK3/6, MKK4, MAPKAPK-2, and heat
shock protein HSP-27 (Cell Signaling) or with antibodies recognizing total p38
(11), JNK (Cell Signaling), MKK3, MKK4, and HSP27 (Santa Cruz), and actin
(Sigma). Tumor necrosis factor alpha (TNF-) was used at a concentration of 5
ng/ml (R&D Systems). Densitometry was measured with NIH Image.
293 cells were cultured in Dulbecco’s modified essential medium supple-
mented with 10% fetal bovine serum, 1% penicillin, and 1% streptomycin.
Transfections were performed in 60-mm dishes using Lipofectamine Plus reagent
(Invitrogen) according to the manufacturer’s specifications for 24 to 36 h. cDNAs
were as previously described (11). Cells were harvested as described above for
MEFs in buffer A. A total of 500 g of lysate was immunoprecipitated for 1 h
with anti-HA (12CA5) antibody, followed by incubation with protein G-Sepha-
rose (Zymed) for 1 h. Immunoprecipitates were washed three times with cold
lysis buffer and once with cold kinase buffer containing 20 mM HEPES (pH 7.4),
10 mM MgCl2, 1 mM dithiothreitol, 0.1 mM sodium vanadate, 10 mM -glyc-
erophosphate, and 0.5 mM ATP. Reaction mixtures were incubated at 30°C for
20 min. Lysates and immunoprecipitates were probed with anti-FLAG (Sigma),
anti-HA (12CA5), anti-phospho-MKK3/6 antibody, and anti-phospho-MKK4
antibody.
Thermal challenge of primary fibroblasts. Primary wild-type and
MEKK4K1361R fibroblasts between passages three and five were utilized. For
analysis of MAPK and HSP27 phosphorylation, cells were incubated at 42°C for
the indicated times. Cells were lysed and probed as described above. For analysis
of cell morphology, cells were plated on glass coverslips for 24 h. Cells were
either untreated or preconditioned by incubation at 42°C for 30 min and allowed
to recover for 24 h. Then, cells were either untreated or exposed to lethal heat
shock at 45°C for 45 min. Cells were fixed for 10 min in 3% paraformaldehyde,
permeabilized in phosphate-buffered saline containing 0.1% Triton X for 6 min,
and stained with rhodamine phalloidin and DAPI. Imaging was performed using
an Axiovert 200 M microscope as described above. Imaging software from In-
telligent Imaging Innovations was used to perform nearest-neighbor deconvolu-
tion on 0.1-m sections.
RESULTS
MEKK4 expression during development. Expression of
MEKK4 during development was demonstrated by in situ hy-
bridization analysis that revealed a changing pattern of
MEKK4 gene expression at E8.5, 10.5, and 15.5. With the
exception of the allantois that lacked MEKK4 staining,
MEKK4 was expressed throughout the embryo at E8.5.
MEKK4 expression was especially strong in the developing
neural folds at E8.5 (Fig. 1A). At E10.5, MEKK4 was promi-
nently expressed along the ventral spinal cord (Fig. 1B) and in
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the neuroepithelium (Fig. 1C). By E15.5, MEKK4 was ex-
pressed in most tissues and organs of the embryo (Fig. 1D).
Generation of kinase-inactive MEKK4 mice. To test for the
requirement of MEKK4 kinase activity, we created a mouse
strain that expresses a kinase-inactive MEKK4 instead of the
wild-type protein. The MEKK4 gene was mutated by replace-
ment of the active-site lysine at position 1361 with an arginine
(MEKK4K1361R), producing an inactive kinase (Fig. 2A). In-
activation of the kinase activity of MEKK4 was validated both
in vitro and in vivo. In an in vitro kinase assay, the wild-type
MEKK4 kinase domain phosphorylated both His-MKK6 (Fig.
2B) and glutathione S-transferase (GST)-MKK4 (Fig. 2C). In
contrast, MEKK4K1361R failed to phosphorylate either His-
MKK6 (Fig. 2B) or GST-MKK4 (Fig. 2C). Furthermore, Flag-
MEKK4K1361R was unable to stimulate either of its down-
stream effectors, JNK or p38, in vivo. Wild-type Flag-MEKK4
expression increased JNK (not shown) and p38 (Fig. 2D) phos-
phorylation. In contrast, although Flag-MEKK4K1361R was ex-
pressed at levels similar to that of wild-type Flag-MEKK4, Flag-
MEKK4K1361R did not stimulate phosphorylation of either JNK
(not shown) or p38 (Fig. 2D). With homologous recombination,
two ES cell clones harboring the MEKK4K1361R gene were gen-
erated (Fig. 2E) and used to produce two independent mouse
lines whose genotypes were confirmed by Southern analysis (not
shown) and PCR (Fig. 2F). Importantly, Western blotting of
lysates from MEFs isolated from homozygous E14.5
MEKK4K1361R or wild-type embryos demonstrated the expres-
sion of MEKK4K1361R and MEKK4wt proteins at comparable
levels (Fig. 2G), so that differences in phenotypes found between
MEKK4K1361R and wild-type mice would be attributable to the
loss of MEKK4 kinase activity and not MEKK4 expression. Dur-
ing propagation of the MEKK4K1361R mouse colony, a non-Men-
delian ratio of homozygous MEKK4K1361R mice was observed. At
3 weeks of age, only 9% of the pups were homozygous for the
MEKK4K1361R gene (Table 1), suggesting that the kinase activity
of MEKK4 plays an important role in development. Embryos
isolated in timed breedings at early and late gestation times re-
vealed the expected numbers of MEKK4K1361R embryos even at
E18.5, suggesting the pups were dying perinatally (Table 1). Male
mice homozygous for MEKK4K1361R that survived to adulthood
were found to be infertile due to reduced sperm count and mo-
tility (not shown). Thus, we used animals generated from het-
erozygous crosses, allowing littermate controls for all the studies.
MEKK4K1361R embryos exhibit skeletal and neural tube
defects (NTDs). Skeletal defects including asymmetric sterno-
costal associations, scoliosis, and vertebral malformations were
the most common phenotypes associated with homozygous
expression of MEKK4K1361R. Seventy-five percent of the fe-
tuses homozygous for MEKK4K1361R exhibited misalignment
of sternocostal associations (Fig. 3A, B, and D). Only 5 to 8%
of heterozygote fetuses showed this phenotype (Fig. 3D), but
when present the misalignment of sternocostal associations in
heterozygotes was often exaggerated with severe curvature of
the sternum and missing ribs (Fig. 3C). In addition to defective
rib attachment, vertebral malformations were observed, as
shown by the prominent curvature of the spine of a heterozy-
gote fetus (Fig. 3F and H), compared to a normal wild-type
control (Fig. 3E and G). Skeletal defects were not due to
defective chondrogenesis, as Alcian blue staining of micromass
cultures derived from E11.5 limb buds showed that chondro-
genesis was identical in MEKK4wt, MEKK4K1361R/wt, and
MEKK4K1361R fetuses (not shown). Additionally, scoliosis of
the axial skeleton (Fig. 3J) and bone remodeling of the tail
(Fig. 3K) were detected in x-rays of adults homozygous for
MEKK4K1361R, compared to wild-type controls (Fig. 3I).
As described above, homozygous expression of MEKK4K1361R
FIG. 1. MEKK4 expression during embryonic development visual-
ized by in situ hybridization with a RNA probe to the N-terminal half
of MEKK4. (A) Whole-mount embryo in situ hybridization for
MEKK4 at E8.5. The solid arrow indicates neural folds, and the open
arrow indicates the allantois. (B) Whole-embryo in situ hybridization
for MEKK4 at E10.5. (C) In situ hybridization for MEKK4 in cryo-
sections isolated at E10.5. The arrowhead denotes neuroepithelium.
(D) In situ hybridization for MEKK4 in cryosections of embryos iso-
lated at E15.5.
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caused a perinatal lethality in approximately two-thirds of the
pups (Table 1). Of surviving MEKK4K1361R pups, 7% displayed a
sacral spina bifida, consisting of a curl proximal to the tail root
and an open spinal cord and vertebral canal covered by skin
growth shortly after birth (Fig. 4A). Examination of litters imme-
diately after birth revealed dead pups; dead MEKK4K1361R pups
frequently exhibited severe open spine defects (Fig. 4B) and oc-
casionally showed rachischisis (Fig. 4C), craniorachischisis (not
shown), and omphalocele (open abdominal wall) (Fig. 4D), sug-
gesting that MEKK4K1361R pups were dying from neural tube and
body wall closure defects. To further evaluate the cause of mor-
tality in the MEKK4K1361R pups, fetuses were isolated at E18.5
and processed for histology. Compared to littermate controls
(Fig. 4E), 20% of MEKK4K1361R fetuses exhibited spina bifida
(Fig. 4F). Examination of sections revealed that all organs were
grossly normal (not shown). Omphalocele (Fig. 4H) and exen-
cephaly (Fig. 4I) were also observed in E14.5 embryos. Quanti-
tation of NTDs showed that half of the embryos homozygous for
the mutation exhibited NTDs (Table 2). Interestingly, 25% of the
embryos heterozygous for the mutation had NTDs, suggesting
that the mutant MEKK4 interferes with the signaling of the wild-
type protein (Table 2). Neural tube closure occurs during embry-
onic days 8 to 10 (13). TUNEL staining of E9.5 embryos revealed
increased apoptosis in the hindbrains of 100% of the exencephalic
MEKK4K1361R embryos relative to wild-type littermates (Fig. 4J
and K). Apoptosis was not altered in the nonexencephalic
MEKK4K1361R embryos (not shown). Enhanced apoptosis in the
hindbrain has been previously shown to result in failure of neural
FIG. 2. Targeted replacement of the MEKK4 gene with a full-length kinase-inactive MEKK4K1361R. (A) Schematic diagram of MEKK4 gene,
the targeting vector, and the targeted allele. Two mutations were generated in exon 21. One silent mutation engineered a new SacI restriction site
in exon 21, and the second mutation produced the replacement of the active-site lysine at position 1361 by arginine, resulting in a full-length
inactive kinase. The neomycin resistance positive selection marker was inserted in the reverse orientation in intron 21. The location of the
hybridization probe is indicated. Digestion of genomic DNA with SacI produces the indicated fragments. (B) Mutation of the active site lysine of
MEKK4 (MEKK4K1361R) disrupts the ability of MEKK4 to phosphorylate its substrate MKK6. 293 cells transfected with the HA-MEKK4wt kinase
domain or HA-MEKK4K1361R kinase domain were immunoprecipitated with anti-HA antibody and incubated with purified kinase-inactive
His-MKK6. Phosphorylation of His-MKK6 was detected with anti-phospho-MKK3/6 antibody. The total HA-MEKK4 kinase domain was detected
with an anti-HA antibody. To show equal loading of substrate, Coomassie staining of the His-MKK6 substrate is shown. (C) Mutation of the
active-site lysine of MEKK4 (MEKK4K1361R) disrupts the ability of MEKK4 to phosphorylate its substrate MKK4. 293 cells were transfected and
immunoprecipitated as described in the legend to panel C and then incubated with inactive GST-MKK4. Phosphorylation of GST-MKK4 was
detected with anti-phospho-MKK4 antibody. The total HA-MEKK4 kinase domain was detected with an anti-HA antibody. To show equal loading,
the GST-MKK4 substrate was stained with Ponceau. (D) MEKK4K1361R is unable to activate p38. 293 cells were cotransfected with Flag-p38 and
either Flag-MEKK4wt or Flag-MEKK4K1361R, and blots were probed as indicated. (E) Southern blot analysis of SacI-digested genomic DNA from
two independent ES cell lines that were injected into C57BL/6 blastocysts and used to generate two independent heterozygous MEKK4K1361R
mouse lines. (F) PCR analysis of genomic DNA isolated from tail clips from 3-week-old pups with primers in exons 21 and 22. (G) Western blot
analysis of MEKK4 protein expression in lysates prepared from mouse embryo fibroblasts generated from littermate E14.5 embryos.
TABLE 1. Genotypes of offspring from heterozygous MEKK4wt/
MEKK4K1361R intercrosses
Stage Total
No. with genotype
MEKK4wt/wt MEKK4K1361R/wt MEKK4K1361R/K1361R
Postnatal 498 146 306 46
E17.5/E18.5 44 14 18 12
E9.5/E11.5 42 11 17 14
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tube closure and increased neonatal lethality (16, 29). Our data
show a dysregulation of cell death in the hindbrain and suggest
that MEKK4 kinase activity plays an antiapoptotic role in embry-
onic brain development. In summary, these data demonstrate a
previously undescribed role for MEKK4 kinase activity in axial
skeleton patterning and confirm a previously described role for
MEKK4 in neural tube closure (6).
MKK3/6 phosphorylation is decreased in hindbrains of E9.5
MEKK4K1361R embryos. MEKK4 is a MAP3K that activates
JNK and p38 MAPKs (11, 31), suggesting that developmental
FIG. 3. Skeletal defects in mice expressing kinase-inactive MEKK4K1361R. Bone (Alizarin red) and cartilage (Alcian blue) staining of ribcages
from wild-type (A), homozygous knock-in of MEKK4K1361R (B), and heterozygote (C) fetuses isolated at E18.5, showing asymmetric attachment
of sternocostal connections. (D) Quantitation of the frequency of rib misalignment in fetuses from heterozygote crosses. Dorsal views of whole
animal bone and cartilage staining in wild-type (E and G) and a heterozygous knock-in of MEKK4K1361R (F and H), showing severe curvature of
the spine, are shown. Magnification of vertebral columns of wild-type (G) and heterozygous mutant (H) fetuses, showing misalignment of vertebra
in the mutant fetus. X-ray films showing scoliosis (J) and an abnormal tail (K) in homozygous knock-in MEKK4K1361R adult mice are compared
to the wild type (I). Black arrowheads (E and F) indicate the area of vertebral column seen in the enlarged insets (G and H); the white arrowhead
(J) indicates scoliosis; the white arrow (K) indicates bone remodeling in the tail.
TABLE 2. Quantitation of NTDs in embryos from heterozygous
MEKK4wt/MEKK4K1361R intercrosses
Genotype Total
No. with phenotypea % of embryos
with NTDsEX SB EX  SB
MEKK4wt/wt 20 0 0 0 0
MEKK4K1361R/wt 24 3 1 2 25
MEKK4K1361R/K1361R 15 5 2 1 53
a EX, exencephaly; SB, spina bifida.
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defects in skeletogenesis and neural tube closure in the
MEKK4K1361R embryos may be due to disruption of either the
JNK or p38 pathways. Although we previously used phospho-
specific antibodies for JNK and for p38 to detect phosphory-
lation in tissue culture cells, the antibodies were not sensitive
enough to detect phosphorylation of JNK or p38 in our cryo-
sections from E9.5 embryos. Therefore, we examined phos-
phorylation of the MAP2Ks that regulate JNK and p38. In
sections from wild-type E9.5 embryos, phosphorylation of
MKK3/6 was detected in the neuroepithelium of the forebrain
and hindbrain and in the mesenchyme (Fig. 5A and AA).
Examination of the phosphorylation status of MKK3/6 in hind-
brains of exencephalic E9.5 embryos homozygous for
MEKK4K1361R revealed a striking loss of phospho-MKK3/6
relative to normal hindbrains from wild-type littermate con-
trols (Fig. 5A, D, AA, and DD). Quantitation of the phosphor-
ylation of MKK3/6 in the neuroepithelium of the hindbrain
revealed a 40% decrease in MKK3/6 phosphorylation in mu-
tant hindbrains (Fig. 5G). The loss of MKK3/6 phosphoryla-
tion suggests that p38 is chronically inhibited in MEKK4K1361R
embryos. A similar loss of phospho-MKK3/6 was also observed
in nonexencephalic MEKK4K1361R hindbrains (not shown), in-
dicating that some embryos can escape the loss of MEKK4
kinase activity, consistent with the incomplete penetrance of
the mutant phenotype.
TUNEL staining of sections revealed enhanced apoptosis in
the hindbrain of exencephalic MEKK4K1361R embryos relative
to that in wild-type controls (Fig. 5B and E). Significantly,
apoptotic cells were completely excluded from sites with high
phospho-MKK3/6 staining (Fig. 5C and F). Phosphorylation of
MKK4 was not altered in the mutant hindbrain relative to the
wild-type control (Fig. 5H-K). Further, quantitation of phos-
pho-MKK4 fluorescence indicated that phospho-MKK4 levels
were not significantly different between wild-type and mutant
hindbrains (Fig. 5L). As predicted, phosphorylation of MEK1
and MEK2, MKKs not regulated by MEKK4, was not altered
in the mutant hindbrains (Fig. 5M to Q). These data demon-
strate that MEKK4K1361R expression selectively disrupted the
MKK3/6 and p38 pathway, consistent with MEKK4 regulation
of MKK3/6 and p38 being necessary for normal neural tube
development.
Upon activation by MKK3/6, p38 translocates to the nucleus
where it phosphorylates multiple downstream targets, includ-
ing the kinase MAPKAPK-2 (28). Perturbation of p38 activation
in MEKK4K1361R embryos was further established by examina-
tion of phosphorylation by MAPKAPK-2, phosphorylation that
occurs directly and exclusively via p38 (28). As shown in Fig. 5R
to U, phosphorylation of MAPKAPK-2 was detected in cells
lining the ventricles, neuroepithelial cells of the forebrain and
hindbrain, and mesenchymal cells of wild-type embryos. Signifi-
FIG. 4. Neonates homozygous for MEKK4K1361R die at birth due
to severe open neural tube and spine defects. (A) Posterior view of a
normal adult wild-type mouse and the curly tail-spina bifida phenotype
in a mouse homozygous for kinase-inactive MEKK4K1361R. (B) Dorsal
view of dead MEKK4K1361R neonate, showing open spine. (C) Dorsal
view of dead homozygous MEKK4K1361R neonate, showing rachischi-
sis. (D) Ventral view of dead neonate homozygous for MEKK4K1361R,
showing omphalocele. (E and F) Transverse sections taken from par-
affin-embedded E18.5 fetuses stained with hematoxylin-eosin. (E) Nor-
mal spinal chord in heterozygote littermate control. (F) Open spinal
chord in MEKK4K1361R fetus with spina bifida. (G to I) Embryos
isolated at E14.5. Normal wild-type embryo (G) and mutant hetero-
zygote embryos with omphalocele (H) or exencephaly (I). The arrow-
head (H) indicates omphalocele and the arrow (I) indicates exen-
cephaly. (J and K) TUNEL-labeled 10-m cryosections from
littermate E9.5 embryos. Apoptotic cells are shown in green. (J) The
forebrain (FB) and hindbrain (HB) are closed in the wild-type embryo.
(K) The hindbrain (HB) remains open and apoptosis is increased in a
MEKK4K1361R mutant.
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FIG. 5. Inhibition of MKK3/6 and MAPKAPK-2 phosphorylation in MEKK4K1361R hindbrains. Cryosections from wild-type (A to C, H, I, M,
N, and R to U) and homozygous MEKK4K1361R (D to F, J, K, O, P, and V to Y) E9.5 embryos isolated from timed heterozygote matings. (A and
D) Phosphorylation of MKK3/6 is decreased in the hindbrains of MEKK4K1361R E9.5 embryos relative to wild-type littermates. A phospho-specific
antibody for MKK3/6 was used to immunostain sections. (AA and DD) Enlarged insets of panels A and D, showing decreased phospho-MKK3/6
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cantly, phosphorylation of MAPKAPK-2 was detected in cells
located at the site of neural tube closure in the hindbrain
(Fig.5RR). This phosphorylation was significantly decreased in
MEKK4K1361R embryos (Fig. 5V and Y). Quantitation of phos-
pho-MAPKAPK-2 fluorescence intensity in the hindbrain re-
vealed a 35% decrease in exencephalic hindbrains (Fig. 5Z), and
a 27.5% decrease in phospho-MAPKAPK-2 staining was mea-
sured in nonexencephalic MEKK4K1361R hindbrains (not shown).
This result is consistent with the diminished MKK3/6 activity in
both the exencephalic and nonexencephalic hindbrains; the
MEKK4K1361R phenotype is characteristic of many mutations in
the developing embryo that demonstrate incomplete penetrance.
Inhibition of the p38 pathway by endogenous MEKK4K1361R
expression in mouse embryonic fibroblasts. To confirm the
role of MEKK4 in regulating the p38 pathway, we examined
primary fibroblasts prepared from MEKK4K1361R and litter-
mate wild-type embryos. A consistent and highly reproducible
effect of MEKK4K1361R expression in multiple primary and
immortalized MEF preparations was a marked inhibition of
p38 activity in cycling cells (Fig. 6A). The inhibition of p38
activity in cycling cells in the presence of 10% serum indicates
that p38 is chronically inhibited in nonstressed MEKK4K1361R
cells. However, there was no difference in acute p38 stimula-
tion by the inflammatory cytokine TNF- that does not utilize
MEKK4 for p38 activation (Fig. 6B) (38). Phosphorylation of
the MAP2Ks MKK3, MKK4, and MKK6 that phosphorylate
p38 were also measured. Phosphorylation of MKK4 was not
inhibited in MEKK4K1361R cells and P-MKK6 levels were un-
detectable under these conditions in either wild-type or mutant
MEFs (not shown). Similar to our findings with the hindbrains
of MEKK4K1361R embryos, phosphorylation of MKK3 was
completely inhibited in cycling MEKK4K1361R fibroblasts,
whereas TNF--stimulated phospho-MKK3 was unaffected
(Fig. 6C). These data demonstrate that p38 and MKK3 are
chronically repressed in MEKK4K1361R fibroblasts. Reduced
phosphorylation of p38 in cycling cells is not due to changes in
MKK4 phosphorylation but is attributable to the decreased
activation of MKK3 and possibly MKK6. Similar to findings in
mutant hindbrains, phosphorylation of MAPKAPK-2 was also
inhibited in mutant fibroblasts. There are two isoforms of
MAPKAPK-2, a 370-amino-acid form and a larger 400-amino-
acid form (28), and phosphorylation of both isoforms was
decreased in primary MEKK4K1361R fibroblasts (Fig. 6D).
However, phosphorylation of both JNK1/2 and ERK1/2 was
similar in wild-type and kinase-inactive MEKK4 cells (Fig.
6D).
As described in Fig. 3 and 5, MEKK4K1361R embryos exhibit
increased apoptosis in the hindbrain neuroepithelium. The
small heat shock protein HSP27 is phosphorylated by
MAPKAPK-2 and promotes stability of the actin cytoskeleton
and cell survival (9, 19, 28). Phosphorylation of HSP27 in
cycling cells was reduced in MEKK4K1361R fibroblasts relative
to wild-type controls, suggesting that MEKK4 regulates steady-
state levels of phospho-HSP27 (Fig. 6D). In addition, inhibition of
the heat shock response was observed. As shown in Fig. 6E, heat
shock-induced activation of p38 is reduced in MEKK4K1361R fi-
broblasts relative to wild-type controls, whereas JNK activation by
heat shock was similar (Fig. 6E). HSP27 phosphorylation in re-
sponse to heat shock was dramatically reduced in MEKK4K1361R
fibroblasts, consistent with the reduction in p38 activity (Fig. 6F).
Integrity of the actin microfilaments in MEKK4K1361R fibroblasts
was markedly reduced in response to heat shock, resulting in
increased cell retraction relative to wild-type MEFs (Fig. 7). Pre-
conditioning of cells at 42°C failed to protect actin filaments in
MEKK4K1361R fibroblasts from heat stress at 45°C, consistent
with the diminshed phosphorylation of HSP27 at 42C (Fig. 6F
and Fig. 7). These data show the functional consequence of the
loss of MEKK4 kinase activity in regulation of the actin cytoskel-
eton controlled by HSP27. The findings demonstrate that
MEKK4K1361R-expressing cells are susceptible to specific stresses.
DISCUSSION
Neural tube and skeletal defects are disabling human con-
genital defects, with neural tube defects being the second most
common human birth defect (8, 39). Studies of mouse models
that impact neural tube and skeletal development, such as the
MEKK4K1361R mouse, provide valuable insight into the mech-
anisms of these processes. Approximately 75% of embryos
homozygous for MEKK4K1361R have skeletal patterning de-
fects, while 50% of the MEKK4 kinase-inactive embryos have
neural tube defects including spina bifida and exencephaly.
Exencephaly resulted from enhanced apoptosis in the hind-
brains of E9.5 mutant embryos, suggesting that MEKK4 plays
an antiapoptotic role in the developing hindbrain.
Inhibition of p38 activity in MEKK4K1361R cycling fibro-
in MEKK4K1361R hindbrain. (B and E) TUNEL staining of sections showing enhanced apoptosis in the hindbrain of the MEKK4K1361R embryo.
(C and F) Overlay of the phospho-MKK3/6 and TUNEL staining, showing the exclusion of apoptotic cells from areas with high phospho-MKK3/6
immunostaining. Phospho-MKK3/6 staining is in red, and TUNEL staining is in green. (G) Quantitation of mean phospho-MKK3/6 fluorescence
intensity in the hindbrain. Data represent the means standard error of the mean (SEM) of three samples, each with P values of	0.001, indicating
that differences are statistically significant. (H to K) Phosphorylation of MKK4 is similar in wild-type and mutant hindbrains. Phosphorylation of
MKK4, shown in red, was detected with a phospho-specific antibody to MKK4; nuclei stained with DAPI are in blue. (L) Quantitation of mean
phospho-MKK4 fluorescence intensity in the hindbrain. Data represent the means  SEM of six samples, each with P values of 
0.25, indicating
that differences are not statistically significant. (M to P) Phosphorylation of MEK1/2 is similar in wild-type and mutant hindbrains. Phosphorylation
of MEK1/2, shown in red, was detected with a phospho-specific antibody to MEK1/2; nuclei are shown in blue. (Q) Quantitation of mean
phospho-MEK1/2 fluorescence intensity in the hindbrain. Data represent the means  SEM of nine wild-type and five mutant samples with P
values of
0.15, indicating that differences are not statistically significant. (R to Y) Phosphorylation of MAPKAPK-2 is decreased in the hindbrains
of MEKK4K1361R E9.5 embryos relative to that of wild-type littermates. A phospho-specific antibody for MAPKAPK-2, shown in red, was used to
immunostain sections; nuclei are shown in blue. (Z) Quantitation of mean phospho-MAPKAPK-2 fluorescence intensity in hindbrain. Data
represent the means  SEM of nine wild-type and eight mutant samples with P values of 	0.001, indicating that differences are statistically
significant. (RR) Enlarged inset of R, showing localization of phospho-MAPKAPK-2 at the site of neural tube closure in the wild-type hindbrain.
Forebrain (FB) and hindbrain (HB) are closed in the wild-type embryo. The hindbrain remains open in the MEKK4K1361R mutants. *, P 	 0.001.
The white arrow indicates the site of hindbrain closure.
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blasts corroborates the studies in embryos that MEKK4 is a
primary MAP3K for controlling endogenous p38 activity.
MEKK4 is important for control of p38 by serum growth fac-
tors, independent of p38 stimulation by the inflammatory cy-
tokine TNF-. The mechanism for p38 inhibition in cycling
cells is inhibition of the activation of MKK3/6, which are direct
substrates for MEKK4.
HSP27, which is downstream of p38, is known to protect
cells from apoptosis. HSP27 phosphorylation in cycling
MEKK4K1361R cells is markedly inhibited, consistent with the
reduced activation of p38 and MAPKAPK-2. Further, heat
shock-induced phosphorylation of both p38 and HSP27 was
reduced in MEKK4K1361R cells, suggesting an important role
for MEKK4 in the heat shock-induced stress response. We
could not detect phospho-HSP27 in embryo cryosections, due
to the insensitivity of the available antibodies but not due to
lack of expression, as HSP27 message is constitutively ex-
pressed in the developing central nervous system (21, 35). As
an in vitro validation of MEKK4 regulation of HSP27,
MEKK4K1361R MEFs exposed to heat shock demonstrated a
reduction in the stability of actin microfilaments.
p38 knockout mice with distinctly different phenotypes have
been created by multiple laboratories, but there have been no
reports in these studies of neural tube closure defects (1, 2, 14,
23, 32). However, the existence of four p38 family members
may allow redundant signaling pathways to compensate for the
loss of a single p38 isoform. An antiapoptotic function for p38
has been shown in vitro for macrophages and differentiating
neurons (20, 26). Cleavage of MKK3 by lethal factor induces
macrophage apoptosis by inhibiting p38-dependent expression
of selective NF-B target genes that protect activated macro-
phages from apoptosis (26). During development of cerebellar
granule neurons, calcium influx activates p38, leading to the
activation of MEF2, MEF2-dependent gene transcription, and
cell survival (20). Expression of a dominant negative p38 pro-
moted apoptosis of differentiating neurons that was rescued by
a constitutively activated form of MEF2C, consistent with a
role for p38 in transcriptional control of antiapoptotic proteins
(25). These studies are consistent with our findings that
MEKK4 regulates MKK3/p38/MAPKAPK-2 during develop-
ment, serving a protective, antiapoptotic role.
Concurrent loss of JNK1 and JNK2 protein expression has
been shown to result in defective neural tube development
manifested primarily as exencephaly (30). Significantly, this
phenotype was not observed in single JNK knockout animals
but required the deletion of isoforms 1 and 2 (18, 30). Exen-
cephaly in the JNK1/2 dual-knockout embryos was due to
enhanced apoptosis in the forebrain and decreased apoptosis
in the hindbrain (18). In comparison, we observed increased
apoptosis in the hindbrains of MEKK4K1361R mice, while
MKK4 signaling was not inhibited in MEKK4K1361R fibroblasts
or hindbrains. These differences clearly indicate that loss of
MEKK4 kinase activity does not mimic the JNK knockout. The
developmental defects observed with MEKK4K1361R mice are
due to mechanisms, in part involving inhibited p38 activity. We
cannot rule out a contribution of JNK dysregulation in the
MEKK4K1361R phenotype, but there is no measurable loss of
phospho-MKK4 in the developing neuroepithelium of
MEKK4K1361R-expressing mice.
MEKK4 is a large 180-kDa protein with a single catalytic
domain but with multiple interaction domains that have been
shown to bind Rac, Cdc42, Ccd1, Axin, and GADD45, -,
and - (11, 22, 37). To preserve protein interactions and pre-
clude compensation by other proteins, we used a knock-in
strategy to create a point mutation in MEKK4, substituting the
active site lysine and selectively inhibiting kinase activity. This
mutant mouse enables us to ascertain effects that are solely
attributable to a loss of kinase activity, as opposed to deletion
of the MEKK4 gene. As predicted, overlapping phenotypes
were observed for the MEKK4 knockout and the MEKK4
kinase-inactive mouse. Common features are reduced phos-
phorylation of p38 in cycling fibroblasts and increased embry-
onic lethality with neural tube closure defects. Chi et al. attrib-
uted the neural tube defects to a very modest decrease in
MKK4 phosphorylation without a change in JNK phosphory-
lation (5, 6). We observed a significantly stronger phenotype
with additional defects in the MEKK4K1361R mouse. The dom-
inant phenotype of MEKK4K1361R mice with severe skeletal
patterning defects including rib malformations and scoliosis
was not described for MEKK4 knockout mice. Also,
MEKK4K1361R mice are infertile, unlike MEKK4 knockout
mice, which have normal reproductive capacity (5). Some of
the differences in the phenotypes of MEKK4K1361R knock-in
and MEKK4 knockout mice may be due to differences in
genetic backgrounds. Studies of MEKK4K1361R knock-in mice
were performed with a mixed 129–C57BL/6 background; the
studies of the MEKK4 knockout were performed on both a
mixed 129–C57BL/6 background and a C57BL/6 background
(5, 6). It is our belief that a kinase-inactive MEKK4 protein,
expressed at levels similar to that of the wild-type kinase, is a
better indicator of the function of MEKK4 kinase signaling
than a null mutant. The behavior of the MEKK4K1361R mutant
is much like that predicted for a high-affinity, selective inhibi-
tor of MEKK4. The mutant MEKK4 protein occupies its space
in the cell, and expression is from the endogenous gene by the
MEKK4 promoter.
It is important to contrast the MEKK4 kinase-inactive phe-
notype to that of knockouts for downstream kinases controlled
by MEKK4. MAP3Ks provide selectivity for activation of
MAPKs by upstream stimuli, and there are multiple MAP3Ks
that regulate the MKK3/MKK6/p38 pathway (15). The inhibi-
tion of serum, but not TNF- activation of p38 in
MEKK4K1361R fibroblasts, demonstrates the selective role of
MEKK4 in regulating the p38 pathway. For this reason, the
MEKK4K1361R phenotype will not be strictly mimicked by the
MKK3/MKK6, p38, or MAPKAPK-2 knockouts. Similarly,
MAPKAPK-2 is only one of many p38 substrates; therefore,
the MAPKAPK-2 knockout is phenotypically different from
the p38 knockout or MEKK4K1361R knock-in. For example, the
MAPKAPK-2 knockout mouse shows protection from many
pathophysiological stress stimuli that induce expression of
TNF- or interleukin-1 (17), but it is otherwise overtly normal
and fertile. This contrasts with p38 knockouts that have vas-
cular, hematopoietic, and placental defects (14), even though
MAPKAPK-2 is clearly a p38 substrate. Similarly, kinase-inac-
tive MEKK4 mice have both skeletal patterning and neurula-
tion dysregulation, a phenotype not observed with any MAPK
knockout but observed with the ablation of the scaffolding
proteins TRAF4 and disheveled-2 (12, 27). Our results suggest
that MAP3K kinase-inactive knock-ins will aid in defining the
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FIG. 6. Inhibition of the p38 pathway in MEKK4K1361R MEFs.
(A) Phosphorylation of p38 is inhibited in immortalized cycling ho-
mozygous and heterozygous MEFs generated from littermate E14.5
embryos. Phosphorylation of p38 (B) and MKK3 (C) in MEFs gener-
ated from primary cycling homozygous MEKK4K1361R embryos and
littermate wild-type controls in cycling cells in response to TNF-.
MEFs were stimulated for the indicated times, and 15 g of lysate was
probed with total and phospho-specific antibodies to MKK3, MKK4,
p38, and actin. (D) Phosphorylation of MKK3, p38, MAPKAPK-2, and
Hsp27 is inhibited in MEKK4K1361R primary cycling MEFs. A total of
15 g of lysate was probed with total and phospho-specific antibodies.
The quantitation represents densitometry in relative units compared to
the densitometry of actin for each sample. (E) Phosphorylation of p38
in response to heat shock is inhibited in MEKK4K1361R MEFs. Primary
cycling MEFs were incubated at 42°C for the indicated times. A total
of 25 g of lysate was probed with the indicated total and phospho-
specific antibodies. (F) Phosphorylation of HSP27 in response to heat
shock is inhibited in MEKK4K1361R MEFs. Primary cycling MEFs were
incubated at 42°C for the indicated times. A total of 25 g of lysate was
probed with the indicated total and phospho-specific antibodies.
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complexity of MAPK integration with developmental and
physiological responses that are not readily apparent with ab-
lation of MAPK expression (15).
ACKNOWLEDGMENTS
These studies were supported by NIH grants GM30324 and
DK37871.
We have no financial conflicts of interest related to these studies.
We thank Pamela J. Cuevas for her expertise in evaluation of the
X-ray images. We also acknowledge the technical assistance of Vir-
ginia Godfrey and the Lineberger Cancer Center Histopathology
Core. We also thank Yongqin Wu for her work on E10.5 in situ
hybridizations. We thank G. T. Rosenthal of the UCHSC for technical
assistance with the mouse colony.
REFERENCES
1. Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A.
Valladares, L. Perez, R. Klein, and A. R. Nebreda. 2000. Essential role of
p38 MAP kinase in placental but not embryonic cardiovascular develop-
ment. Mol. Cell 6:109–116.
2. Allen, M., L. Svensson, M. Roach, J. Hambor, J. McNeish, and C. A. Gabel.
2000. Deficiency of the stress kinase p38 results in embryonic lethality:
characterization of the kinase dependence of stress responses of enzyme-
deficient embryonic stem cells. J. Exp. Med. 191:859–870.
3. Bhasin, N., E. Kernick, X. Luo, H. E. Seidel, E. R. Weiss, and J. M. Lauder.
2004. Differential regulation of chondrogenic differentiation by the serotonin
2B receptor and retinoic acid in the embryonic mouse hindlimb. Dev. Dyn.
230:201–209.
4. Brancho, D., N. Tanaka, A. Jaeschke, J. J. Ventura, N. Kelkar, Y. Tanaka,
M. Kyuuma, T. Takeshita, R. A. Flavell, and R. J. Davis. 2003. Mechanism
of p38 MAP kinase activation in vivo. Genes Dev. 17:1969–1978.
5. Chi, H., B. Lu, M. Takekawa, R. J. Davis, and R. A. Flavell. 2004.
FIG. 7. Increased thermosensitivity of actin microfilaments in primary MEKK4K1361R fibroblasts. Primary fibroblasts from littermate
MEKK4K1361R (A to L) or wild-type (M to X) embryos were plated on coverslips. Cells were maintained at 37°C (A to D and M to P), incubated
at 45°C for 45 min (E to H and Q to T), or heated at 42°C for 30 min (preconditioning), followed by recovery for 24 h at 37°C and heat shock
at 45°C for 45 min (I to L and U to X). Cells were fixed and stained with rhodamine phalloidin to detect polymerized actin (red) and DAPI to
stain nuclei (blue). Two sample fields of deconvolved 0.1-m sections are shown. Black-and-white images show polymerized actin alone. Bar, 25
M.
8958 ABELL ET AL. MOL. CELL. BIOL.
GADD45/GADD45 and MEKK4 comprise a genetic pathway mediating
STAT4-independent IFN production in T cells. EMBO J. 23:1576–1586.
6. Chi, H., M. R. Sarkisian, P. Rakic, and R. A. Flavell. 2005. Loss of mitogen-
activated protein kinase kinase kinase 4 (MEKK4) results in enhanced
apoptosis and defective neural tube development. Proc. Natl. Acad. Sci.
USA 102:3846–3851.
7. Compagni, A., M. Logan, R. Klein, and R. H. Adams. 2003. Control of
skeletal patterning by ephrin B1-EphB interactions. Dev. Cell 5:217–230.
8. Copp, A. J., N. D. Greene, and J. N. Murdoch. 2003. The genetic basis of
mammalian neurulation. Nat. Rev. Genet. 4:784–793.
9. Garrido, C., S. Gurbuxani, L. Ravagnan, and G. Kroemer. 2001. Heat shock
proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys.
Res. Commun. 286:433–442.
10. Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of
mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol.
11:211–218.
11. Gerwins, P., J. L. Blank, and G. L. Johnson. 1997. Cloning of a novel
mitogen-activated protein kinase kinase kinase, MEKK4, that selectively
regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 272:8288–
8295.
12. Hamblet, N. S., N. Lijam, P. Ruiz-Lozano, J. Wang, Y. Yang, Z. Luo, L. Mei,
K. R. Chien, D. J. Sussman, and A. Wynshaw-Boris. 2002. Dishevelled 2 is
essential for cardiac outflow tract development, somite segmentation and
neural tube closure. Development 129:5827–5838.
13. Harris, M. J., and D. M. Juriloff. 1999. Mini-review: toward understanding
mechanisms of genetic neural tube defects in mice. Teratology 60:292–305.
14. Ihle, J. N. 2000. The challenges of translating knockout phenotypes into gene
function. Cell 102:131–134.
15. Johnson, G. L., H. G. Dohlman, and L. M. Graves. 2005. MAPK kinase
kinases (MKKKs) as a target class for small-molecule inhibition to modulate
signaling networks and gene expression. Curr. Opin. Chem. Biol. 9:325–331.
16. Juriloff, D. M., and M. J. Harris. 2000. Mouse models for neural tube closure
defects. Hum. Mol. Genet. 9:993–1000.
17. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H. D.
Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced
TNF-alpha biosynthesis. Nat. Cell Biol. 1:94–97.
18. Kuan, C. Y., D. D. Yang, D. R. Samanta Roy, R. J. Davis, P. Rakic, and R. A.
Flavell. 1999. The Jnk1 and Jnk2 protein kinases are required for regional
specific apoptosis during early brain development. Neuron 22:667–676.
19. Lavoie, J. N., H. Lambert, E. Hickey, L. A. Weber, and J. Landry. 1995.
Modulation of cellular thermoresistance and actin filament stability accom-
panies phosphorylation-induced changes in the oligomeric structure of heat
shock protein 27. Mol. Cell. Biol. 15:505–516.
20. Mao, Z., A. Bonni, F. Xia, M. Nadal-Vicens, and M. E. Greenberg. 1999.
Neuronal activity-dependent cell survival mediated by transcription factor
MEF2. Science 286:785–790.
21. Michaud, S., R. Marin, and R. M. Tanguay. 1997. Regulation of heat shock
gene induction and expression during Drosophila development. Cell. Mol.
Life Sci. 53:104–113.
22. Mita, H., J. Tsutsui, M. Takekawa, E. A. Witten, and H. Saito. 2002. Reg-
ulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory
domain and GADD45 binding. Mol. Cell. Biol. 22:4544–4555.
23. Mudgett, J. S., J. Ding, L. Guh-Siesel, N. A. Chartrain, L. Yang, S. Gopal,
and M. M. Shen. 2000. Essential role for p38 mitogen-activated protein
kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA 97:10454–
10459.
24. Neubuser, A., H. Koseki, and R. Balling. 1995. Characterization and devel-
opmental expression of Pax9, a paired-box-containing gene related to Pax1.
Dev. Biol. 170:701–716.
25. Okamoto, S., D. Krainc, K. Sherman, and S. A. Lipton. 2000. Antiapoptotic
role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2
transcription factor pathway during neuronal differentiation. Proc. Natl.
Acad. Sci. USA 97:7561–7566.
26. Park, J. M., F. R. Greten, Z. W. Li, and M. Karin. 2002. Macrophage
apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Sci-
ence 297:2048–2051.
27. Regnier, C. H., R. Masson, V. Kedinger, J. Textoris, I. Stoll, M. P. Chenard,
A. Dierich, C. Tomasetto, and M. C. Rio. 2002. Impaired neural tube closure,
axial skeleton malformations, and tracheal ring disruption in TRAF4-defi-
cient mice. Proc. Natl. Acad. Sci. USA 99:5585–5590.
28. Roux, P. P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein
kinases: a family of protein kinases with diverse biological functions. Micro-
biol. Mol. Biol. Rev. 68:320–344.
29. Ruland, J., G. S. Duncan, A. Elia, I. del Barco Barrantes, L. Nguyen, S. Plyte,
D. G. Millar, D. Bouchard, A. Wakeham, P. S. Ohashi, and T. W. Mak. 2001.
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-B
and neural tube closure. Cell 104:33–42.
30. Sabapathy, K., W. Jochum, K. Hochedlinger, L. Chang, M. Karin, and E. F.
Wagner. 1999. Defective neural tube morphogenesis and altered apoptosis in
the absence of both JNK1 and JNK2. Mech. Dev. 89:115–124.
31. Takekawa, M., F. Posas, and H. Saito. 1997. A human homolog of the yeast
Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced ac-
tivation of the p38 and JNK pathways. EMBO J. 16:4973–4982.
32. Tamura, K., T. Sudo, U. Senftleben, A. M. Dadak, R. Johnson, and M.
Karin. 2000. Requirement for p38 in erythropoietin expression: a role for
stress kinases in erythropoiesis. Cell 102:221–231.
33. Uhlik, M. T., A. N. Abell, N. L. Johnson, W. Sun, B. D. Cuevas, K. E.
Lobel-Rice, E. A. Horne, M. L. Dell’Acqua, and G. L. Johnson. 2003. Rac-
MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic
shock. Nat. Cell Biol 5:1104–1110.
34. Wada, T., and J. M. Penninger. 2004. Mitogen-activated protein kinases in
apoptosis regulation. Oncogene 23:2838–2849.
35. Walsh, D., Z. Li, Y. Wu, and K. Nagata. 1997. Heat shock and the role of the
HSPs during neural plate induction in early mammalian CNS and brain
development. Cell. Mol. Life Sci. 53:198–211.
36. Wilkinson, D. G., S. Bhatt, and B. G. Herrmann. 1990. Expression pattern of
the mouse T gene and its role in mesoderm formation. Nature 343:657–659.
37. Wong, C. K., W. Luo, Y. Deng, H. Zou, Z. Ye, and S. C. Lin. 2004. The DIX
domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal kinase activation
by Axin and dishevelled through distinct mechanisms. J. Biol. Chem. 279:
39366–39373.
38. Yang, J., Y. Lin, Z. Guo, J. Cheng, J. Huang, L. Deng, W. Liao, Z. Chen, Z.
Liu, and B. Su. 2001. The essential role of MEKK3 in TNF-induced NF-B
activation. Nat. Immunol. 2:620–624.
39. Zelzer, E., and B. R. Olsen. 2003. The genetic basis for skeletal diseases.
Nature 423:343–348.
VOL. 25, 2005 MEKK4 KINASE-INACTIVE KNOCK-IN MICE 8959
